
Epitome Biopharmaceuticals Llp
Manages marketing, manufacturing, and distribution of pharmaceuticals and medical products.
Manages marketing, manufacturing, and distribution of pharmaceuticals and medical products.
South West Delhi, Delhi, India
+91-XXXXXXXXXX
AAN-3695
27 Sep 2018
31 Mar 2022
Roc-Delhi
Limited Liability Partnership
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjeev Kansal ![]() | Designated Partner | 27-Sep-2018 | Current |
Nitin Kansal ![]() | Designated Partner | 27-Sep-2018 | Current |
Enhance accessibility to Epitome Biopharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Epitome Biopharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Sanjeev Kansal is a mutual person
Sanjeev Kansal is a mutual person
There are no Open Charges registered against the LLP as per our records.
Unlock and access historical data on people associated with Epitome Biopharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Epitome Biopharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Epitome Biopharmaceuticals Llp's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Epitome Biopharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2022 with RoC-Delhi.
Sanjeev Kansal was appointed as a Designated Partner was appointed as a Designated Partner on 27 Sep 2018 & has been associated with this company since 6 years 6 months .
Nitin Kansal was appointed as a Designated Partner was appointed as a Designated Partner on 27 Sep 2018 & has been associated with this company since 6 years 6 months .
Epitome Biopharmaceuticals Llp was registered on 27 Sep 2018 with RoC-Delhi & aged 6 years 6 months as per MCA records.
Epitome Biopharmaceuticals Llp was incorporated on 27 Sep 2018.
The Obligation of Contribution of Epitome Biopharmaceuticals Llp is ₹ 1.10 M.
Currently 2 partners are associated with Epitome Biopharmaceuticals Llp.
As per Ministry of Corporate Affairs (Mca), the registered address of Epitome Biopharmaceuticals Llp is H No. R-9 Basement Green Park Extension Hauz Khas Na New, South West Delhi, India, 110016.
The Limited Liability Partnership Identification Number (LLPIN) of Epitome Biopharmaceuticals Llp is AAN-3695.
The most recent Balance Sheet for Epitome Biopharmaceuticals Llp was filed with the ROC on 31 Mar 2022.
Search company & director profiles for free and gain access to critical business data.